Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
Pe'er
Jacob
J
Rowe
Jacob M
JM
Frenkel
Shahar
S
Dann
Eldad J
EJ
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000276:immunology; D001813:Blood-Retinal Barrier / Q000276:immunology; D001814:Blood-Testis Barrier / Q000276:immunology; D001932:Brain Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D056965:Injections, Intraocular; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009919:Orchiectomy; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D012074:Remission Induction; D019572:Retinal Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000601:surgery; D000069283:Rituximab; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D014750:Vincristine / Q000008:administration & dosage; D014821:Vitrectomy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D003561:Cytarabine; D011344:Procarbazine; D000069283:Rituximab; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate